LIVN vs. STVN, GKOS, BLCO, INSP, NARI, IRTC, PRCT, NVST, TMDX, and SLNO
Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.
LivaNova vs.
LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.
Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
LivaNova has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.
Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.
LivaNova received 374 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.66% of users gave LivaNova an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote.
In the previous week, LivaNova and LivaNova both had 8 articles in the media. LivaNova's average media sentiment score of 1.41 beat Stevanato Group's score of 1.21 indicating that LivaNova is being referred to more favorably in the media.
97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 0.7% of Stevanato Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
LivaNova presently has a consensus price target of $61.17, indicating a potential upside of 53.22%. Given LivaNova's stronger consensus rating and higher possible upside, equities research analysts clearly believe LivaNova is more favorable than Stevanato Group.
Summary
LivaNova beats Stevanato Group on 13 of the 17 factors compared between the two stocks.
Get LivaNova News Delivered to You Automatically
Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
LivaNova Competitors List
Related Companies and Tools
This page (NASDAQ:LIVN) was last updated on 3/25/2025 by MarketBeat.com Staff